It has been reported that chemotherapeutic agents, including doxorubicin, induce the activation of NF-κB in cancer cells (Chuang et al, 2002), thereby inducing survival signals that inhibit apoptosis and promote cancer cell growth. Here, NFKB1 is linked to cancer.